T1	Participants 48 73	symptomatic endometriosis
T3	Participants 369 421	All patients had received monthly leuprolide acetate
T2	Participants 117 249	post-treatment effects in endometriosis patients of a 12-month course of GnRH agonist alone or with one of three "add-back" regimens
T4	Participants 269 302	post-treatment follow-up analysis
T5	Participants 678 797	201 patients enrolled in the initial trial, 123 completed at least 280 days of therapy and entered the follow-up period
T6	Participants 1571 1605	symptomatic endometriosis patients
